Objective Analysis and evaluation of cystatin C (Cysc) ,N‐acetyl‐beta‐D‐glucosaminidase (NAG) ,β2‐microglobulin (β2‐MG) ,blood urea nitrogen(BUN) ,serum creatinine(Scr) five biological parameters in the diagnosis of early renal damage caused by the diseases of Systemic lupus eythematosus ,diabetes or high blood pressure .Methods Collecting 61 patients with high blood pressure ,62 patients with systemic lupus eythematosus (SLE) ,59 patients with diabetes ,56 cases of healthy controls .Cysc was e‐valuated by immune transmission turbidimetric method ,latex enhanced immune turbidimetric method was used to detectβ2‐MG ,u‐sing two point method to determine NAG ,enzymatic assay Scr ,UV‐GLDH method was used to measure serum BUN ,and using the statistical method to analyze the data .Results There was no significant difference between healthy controls and patients group (P>0 .05) in BUN and Src levels .However ,there were significant differences in Cysc ,urineβ2‐MG and NAG concentrations (P<0 .01) .Under ROC curve ,the largest square of diagnosis indexes for early renal damage caused by SLE ,diabetes ,high blood pres‐sure were blood NAG ,urineβ2‐MG and Cysc .Compared to a single parameter ,the rate of joint detection in the diagnosis of early re‐nal damage is high ,a joint detection of Cysc ,β2‐MG and urine NAG could enhance the positive rate to 88 .7% ,which was signifi‐cantly higher than the joint detection with two indexes (77 .4% ,70 .9% or 66 .1% ) .Conclusion The most sensitive and specific in‐dex in the diagnosis of early renal damage caused by SLE ,diabetes ,high blood pressure were blood respectively NAG ,urine beta 2‐MG and Cysc .Joint detection has higher detection rate ,sensitivity ,specificity ,and has important clinical value in the early diagnosis of patients with renal damage ,which is suitable for clinical application .

Objective To investigate the therapeutic effects of endoscopic retrograde cholangiopancreatography (ERCP) and laparoscopic bile duct exploration lithotomy (LBDEL) in treatment of intra/extra-hepatic duct stones. Methods There were 110 patients whose intrahepatic stones located in Ⅰ , Ⅱ hepatic duct and 378 patients whose stones only located in the common bile duct. These patients respectively underwent LBDE combined with choledochoscope laser lithotripsy or ERCP combined with endoscopic sphincterotomy (EST) and endoscopic nasobiliary drainage (ENBD) to remove the stones. Common bile ducts were performed primary suture or T tube placement in the LBDEL cases. The evaluation was carried out for perioperative complications and postoperative recovery of the surgical methods. Results The residual stone rate was 31.82% in 110 cases. The rate was higher in ERCP group (51.06%) than that in LBDEL group (17.46%) (P < 0.05). Postoperative recovery was better in LBDEL group than that in ERCP group. The residual stone rate was 8.20% in 378 cases. The rate was lower in ERCP group (3.68%) than that in LBDEL group(11.63%) (P < 0.05). Between the two groups, there had no statistical significance in postoperative recovery. The incidences of bile leakage and pulmonary infection were higher in LBDEL group than in ERCP group. The incidences of abdominal cavity infection, acute pancreatitis, digestive tract perforation and gastrointestinal bleeding were higher in ERCP group than that in LBDEL group. 2 of the 378 patients occurred death were happened digestive tract perforation which were induced during ERCP procedure. Conclusion LBDEL and ERCP demonstrated the same therapeutic effects in the treatment of common bile duct stones. However, ERCP has no large advantages in the treatment of hepatolithiasis, and shows higher complication rates. LBDEL has a significant curative effect for intra-and extrahepatic bile duct calculi and can maintain the integrity of Oddi sphincter. This technology is easy to spread to the basic-level hospital to benefit the majority of patients.

【Objective】 To discuss the case reports concerning anti-CD47 monoclonal antibody interfere in pre-transfusion testing, so as to find mitigation strategies for this drug interference. 【Methods】 Blood transfusion cases in clinical trials concerning CD47 mAb drugs at home and abroad were retrieved from PubMed, Medline, Web of Science, Wanfang data knowledge service platform and CNKI database. The characteristics and solutions of this drug interfering with pre-transfusion testing were analyzed. 【Results】 A total of 26 cases concerning anti-CD47 mAb interference in pretransfusion testing were retrieved, and 16 valid cases were included in this study (All received HU5F9-G4 as anti-CD47 mAb). After treatment with Hu5F9-G4, the discrepancy between forward and reverse blood typing reached 77% in pre-transfusion testing. Panagglutination was presented in antibody screenings, and all(100%) platelet antibody screenings was interfered. These results indicated that Hu5F9-G4 seriously affected the compatibility test of blood transfusion. Methods of eliminating anti-CD47 interference, as well as their advantages and disadvantages were further analyzed. 【Conclusion】 The advantages and disadvantages of eliminating anti-CD47 interference with pre-transfusion testing was analyzed according to its characteristics, which could provide reference for the laboratory testing.

Objective To investigate the expression of microRNA-1290 in pancreatic cancer and its role in invasion and metastasis of pancreatic cancer.Methods The expression of microRNA-1290 in pancreatic cancer tissue microarray and pancreatic cancer cell lines (AsPC-1,BxPC-3,Capan-2,Panc-1,and MIA PaCa-2) were detected by immunohistochemistry and QT-PCR.The pancreatic cancer cell lines Panc-1 and MIA PaCa-2 in logarithmic growth phase were treated with microRNA-1290 inhibitor,and the invasion and metastasis ability of pancreatic cancer cells were detected by Transwell and wound healing asssay.Western Blot was used to detect the expression of invasion and metastasis-associated proteins cyclooxygenase 2 (COX-2) and matrix metalloproteinase 2(MMP-2) in pancreatic cancer cell lines.Results (1) The expression of microRNA-1290 in pancreatic cancer tissues was significantly higher than that in normal pancreatic tissues and adjacent tissues (P ＜ 0.05).(2) Compared with pancreatic normal epithelial cells (HPDE),the expression of microRNA-1290 was significantly higher in different pancreatic cancer cell lines (P ＜ 0.05).The expression level of MicroRNA-1290 in Panc-1 and MIAPaCa-2 pancreatic cancer cells was significantly higher than that in other pancreatic cancer cell lines (P ＜ 0.05).(3) The number of invasive and metastatic cells was significantly decreased after treatment with microRNA-1290 inhibitor (P ＜0.05).(4) The expression of MMP-2 and COX-2 were decreased in Panc-1 and MIAPaCa-2 pancreatic cancer cells treated with MicroRNA-1290 inhibitor.Conclusion The expression of MMP-2 and COX-2 may be involved in the invasion and metastasis of pancreatic cancer cell by regulating the expression of microRNA-1290 in pancreatic cancer.

Objective To analyze the mutation rates of thrombolytic genes antiphospholipid antibody(APOH),thrombo-regulatory protein(THBD)and PC anticoagulant protein(PROC),providing a theoretical basis for the prevention and treatment of thrombolytic diseases in adolescents.Methods A total of 582 cases 16-year-old adolescents who underwent routine physical examination from May to December 2019 were selected as the study objects.The gene loci such as PROC c.574_576del,THBD c.-151G>T and APOHc.461G>A were detected by PCR-RFLP genotyping detection and gene sequencing technology,and statistical analysis was performed on mutation rates.Results PCR-RFLP genotyping detecting of 582 samples showed that the mutation rate of PROC c.574_576del was about 0.69%(4/582),which was lower than the overall mutation rate in the Chinese population(2.4%),while the mutation rates of THBD c.-151G>T and APOHc.461G>A were about 2.92%(17/582)and 12.71%(74/582),which were higher than the overall mutation rates in Chinese population(0.97%,10.27%).Sequencing analysis showed that APOHc.461G>A mutation was linked with APOHc.422T>C and APOHc.1004G>C mutation.Conclusion The mutation rate of thrombolytic gene in adolescents is different from that of the whole population.The mutation rates of APOHc.461G>A and THBD c.-151G>T are higher than those of the whole Chinese population,indicating that timely detection should be used in the diagnosis and treatment of thrombolytic diseases in adolescents.